Navigation Links
Study shows rise in antibiotic resistant pediatric head and neck infections
Date:1/19/2009

Highlights

  • Prevalence of antibiotic-resistant head and neck infections is increasing.
  • There is growing concern in the medical community about an epidemic of community acquired antibiotic resistant infections.
  • Clinicians must be judicious in prescribing antibiotics.

ATLANTA A report by researchers in the Jan. 19, 2009 Archives of Otolaryngology-Head and Neck Surgery shows that there was nationwide increase in the prevalence of pediatric methicillin-resistant Staphylococcus aureus (MRSA) head and neck infections from January 2001 to December 2006.

The increase in antibiotic-resistant infections has become a big concern for researchers and clinicians over the years. MRSA was once a condition that was only found in hospital settings; however, over the last decade MRSA outbreaks have increasingly been found in patients without risk factors.

In an attempt to identify trends in the susceptibility of antibiotic-resistant infections, researchers from Emory University School of Medicine and Children's Healthcare of Atlanta studied data on pediatric patients from nationwide hospitals.

"The growing concern about the recent worldwide MRSA epidemic has fueled the curiosity of the scientific community to gain insight into the clinical and epidemiologic manifestations of this microbe," says Steven E. Sobol, MD, MSc, primary investigator of the study and director of Pediatric Otolaryngology in the Department of Otolaryngology - Head and Neck Surgery at Emory.

"Previous studies have established that skin and soft tissue infections in some communities are due to MRSA," he says. "However, it has been observed in several institutions that there is a significant rise in pediatric head and neck infections as well."

The researchers reviewed a total of 21,009 pediatric head and neck S. aureus infections from 300 hospitals nationwide that occurred between Jan. 1, 2001 and Dec. 31, 2006. Patients ranged in ages from birth to 18.

In 2001, approximately 12 percent of all isolated S. aureus in the study was methicillin resistant. During the following five years, the number steadily rose to more than 28 percent. Overall during those six years there was a 16.3 percent increase in the percentage of resistance for all pediatric head and neck S. aureus infections.

"There is a nationwide increase in the prevalence of MRSA in children with head and neck infections that is alarming," says Sobol. "Clinicians must use antibiotic agents judiciously in order to reduce further antimicrobial drug resistance."

Sobol suggests that there be careful testing of suspected head and neck infections, leading to more appropriate antimicrobial drug selection. He also recommends further studies to gain additional insight into this organism.

Additional study investigators include Iman Naseri, MD, formerly of Emory's Department of OtolaryngologyHead and Neck Surgery and Robert C. Jerris, PhD, Children's Healthcare of Atlanta.

This study was supported by a grant from Alcon Laboratories Inc.

Reference: Nationwide Trends in Pediatric Staphylococcus aureus Head and Neck Infections, Archives of Otolaryngology Head and Neck Surgery/Vol 135 (No. 1): 14-16


'/>"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University
Source:Eurekalert

Related medicine news :

1. Study: Growth in research comes at a steep price
2. National Childrens Study Begins Recruiting
3. A Study In This Months Journal Of Nervous And Mental Disease Reveals Hope For Recovery From Suicidal Thinking And Treatment Resistant Mental Illness
4. Tufts receives NIH grant to study obesity prevention in new immigrants
5. New Research From EBRI: Study Examines Issues in Capping Tax Exclusion of Health Coverage
6. 2009 Most Wired Survey and Benchmarking Study Opens Today
7. Seattle Reproductive Medicine Study Investigates Newly Formulated Medications for Luteal Support in IVF
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Study uses bone marrow stem cells to regenerate skin
10. Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers
11. TPHAC Reaction to Economic Impact Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... Marina del Rey, CA (PRWEB) , ... August ... ... provider of revenue cycle management (RCM) solutions, announced recently the availability of a ... the HIM community in appreciation for their service to the healthcare industry. E/M ...
(Date:8/22/2017)... , ... August 22, 2017 , ... “To Walk Away”: ... on a B17 bomber named Edward Koontz. “To Walk Away” is the creation of ... who has published over two hundred manuscripts in chemistry and religion, as well as ...
(Date:8/22/2017)... ... , ... “Covert Awakening”: Walid’s spiritual journey from Islamic terrorist ... a consultant for the Intelligence Community. For more than ten years, she ... region. Julianne has written hundreds of reports for the US government analyzing ...
(Date:8/22/2017)... ... ... TopConsumerReviews.com recently gave a best-in-class 5-star rating to Energy NADH, a leader ... modern life continually makes more demands on time and energy, people are finding it ... in vicious high/low cycles and can also cause long term health issues. More people ...
(Date:8/21/2017)... ... 22, 2017 , ... PracticeMatch, a company that provides online resources , ... and advanced practitioners like nurse practitioners and physician assistants , will ... of this year. The online career fairs will allow job seekers to connect with ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
(Date:7/26/2017)... 26, 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) ... trial evaluating Altemia TM , an oral therapy for ... Cell Disease (SCD). The SCOT Trial, is a double-blind, ... safety of Altemia TM in pediatric patients aged ... IND 125274. "The ...
Breaking Medicine Technology: